sulfinpyrazone has been researched along with Liver Neoplasms in 2 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
Liver Neoplasms: Tumors or cancer of the LIVER.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhu, Z | 1 |
| Puglisi, J | 1 |
| Connors, D | 1 |
| Stewart, J | 1 |
| Herbst, J | 1 |
| Marino, A | 1 |
| Sinz, M | 1 |
| O'Connell, J | 1 |
| Banks, M | 1 |
| Dickinson, K | 1 |
| Cacace, A | 1 |
| Morrow, CS | 1 |
| Smitherman, PK | 1 |
| Townsend, AJ | 1 |
2 other studies available for sulfinpyrazone and Liver Neoplasms
| Article | Year |
|---|---|
Use of cryopreserved transiently transfected cells in high-throughput pregnane X receptor transactivation assay.
Topics: Biological Assay; Caco-2 Cells; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Membrane Permeabil | 2007 |
Role of multidrug-resistance protein 2 in glutathione S-transferase P1-1-mediated resistance to 4-nitroquinoline 1-oxide toxicities in HepG2 cells.
Topics: 4-Nitroquinoline-1-oxide; ATP Binding Cassette Transporter, Subfamily B; Carcinogens; Carcinoma, Hep | 2000 |